Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2004 Jan 24;328(7433):192.
doi: 10.1136/bmj.328.7433.192.

Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial

Neriman Bayram  1 , Madelon van Wely, Eugenie M Kaaijk, Patrick M M Bossuyt, Fulco van der Veen
Affiliations
Clinical Trial

Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial

Neriman Bayram et al. BMJ. .

Abstract

Objective: To compare the effectiveness of an electrocautery strategy with ovulation induction using recombinant follicle stimulating hormone in patients with polycystic ovary syndrome.

Design: Randomised controlled trial.

Setting: Secondary and tertiary hospitals in the Netherlands.

Participants: 168 patients with clomiphene citrate resistant polycystic ovary syndrome: 83 were allocated electrocautery and 85 were allocated recombinant follicle stimulating hormone.

Intervention: Laparoscopic electrocautery of the ovaries followed by clomiphene citrate and recombinant follicle stimulating hormone if anovulation persisted, or induction of ovulation with recombinant follicle stimulating hormone.

Main outcome measure: Ongoing pregnancy within 12 months.

Results: . The cumulative rate of ongoing pregnancy after recombinant follicle stimulating hormone was 67%. With only electrocautery it was 34%, which increased to 49% after clomiphene citrate was given. Subsequent recombinant follicle stimulating hormone increased the rate to 67% at 12 months (rate ratio 1.01, 95% confidence interval 0.81 to 1.24). No complications occurred from electrocautery with or without clomiphene citrate. Patients allocated to electrocautery had a significantly lower risk of multiple pregnancy (0.11, 0.01 to 0.86).

Conclusion: The ongoing pregnancy rate from ovulation induction with laparoscopic electrocautery followed by clomiphene citrate and recombinant follicle stimulating hormone if anovulation persisted, or recombinant follicle stimulating hormone, seems equivalent to ovulation induction with recombinant follicle stimulating hormone, but the former procedure carries a lower risk of multiple pregnancy.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Flow of participants through trial. *=patients who received recombinant follicle stimulating hormone after electrocautery
Fig 2
Fig 2
Cumulative ongoing pregnancy rate over time from electrocautery or ovulation induction with recombinant follicle stimulating hormone
See this image and copyright information in PMC

References

    1. Franks S. Polycystic ovary syndrome. N Engl J Med 1995;333: 853-61. - PubMed
    1. Balen A, Michelmore K. What is polycystic ovary syndrome? Hum Reprod 2002;17: 2219-27. - PubMed
    1. Homburg R. What is polycystic ovarian syndrome? Hum Reprod 2002;17: 2495-9. - PubMed
    1. Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 1998;83: 2361-5. - PubMed
    1. Jacobs HS, Agrawal R. Complications of ovarian stimulation. Baillierès Clin Obstet Gynaecol 1998;12: 565-79. - PubMed

Publication types

Substances